Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors

Go back to Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
(NYSE: ANRO) Delayed: 25.69 +2.76 (12.04%)
Previous Close $22.93    52 Week High
Open $22.32    52 Week Low
Day High $25.80    P/E N/A 
Day Low $22.32    EPS
Volume 197,503